Alteral Therapeutics ApS - 12 Nov 2024 Form 4 Insider Report for Nordicus Partners Corp (NORD)

Role
10%+ Owner
Signature
/s/ Allan Traugott Wehnert
Issuer symbol
NORD
Transactions as of
12 Nov 2024
Net transactions value
$0
Form type
4
Filing time
10 Dec 2024, 14:04:35 UTC
Previous filing
05 Jun 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction NORD Common stock Other +4,030,903 +319% 5,296,131 12 Nov 2024 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares acquired in connection with the acquisition by Nordicus Partners Corporation through a share exchange with the shareholders of Bio-Convert ApS on November 12, 2024.